BioCentury
ARTICLE | Company News

GlaxoSmithKline, Roivant Sciences deal

January 5, 2015 8:00 AM UTC

Roivant’s Roivant Neurosciences Ltd. subsidiary acquired SB742457 from GlaxoSmithKline. SB742457 has completed four Phase II trials in patients with mild to moderate Alzheimer’s disease (AD). Roivant...